Crucell: Sitemap

About us Crucell at a glance Our mission Our strategy Our values Our history Corporate Social Resp... Crucell worldwide Corporate governance Management Committee Supervisory Board Articles of associat... Code of conduct Whistleblower form	Technology PER.C6® technology PERCIVIA PER.C6® join... Applications Vaccine manufacturing Proteins Gene therapy products Functional genomics Licensing AdVac® technology Detailed description Applications MAbstract® technology Detailed description Applications STAR® technology Detailed description Applications Licensing Virosome technology Detailed description Applications Recombinant Paramyxov... Detailed description Applications Hansenula polymorpha Detailed description Applications Partnering opportunit...	Products Quinvaxem® Hepavax-Gene® MoRu-Viraten® Epaxal® Vivotif® Dukoral® Inflexal® V Questions about produ...
R&D Development Programs Tuberculosis Vaccine Malaria Vaccine Ebola and Marburg Vac... HIV Vaccine RSV HPV Influenza Seasonal Va... Rabies Antibody Combi... Influenza Antibodies Hepatitis C Antibodie... Clinical Trials Scientific Publicatio...	Partners Strategic Partners Marketing & Sales Par... R&D Partners & Licens... Partnering Opportunit...	Investors Johnson & Johnson Acq... Financial Information Annual Reports Quarterly Reports SEC Filings Euronext Filings Press Releases Shareholder meetings AGM 30 June 2011 EGM 8 Feb 2011 EGM 10 Dec 2010 AGM 04 June 2010 AGM 04 June 2010 AGM 05 June 2009 AGM 30 May 2008 AGM 1 June 2007 AGM 2 June 2006 GM 10 January 2006 AGM 2 June 2005 Presentations Webcasts Transcripts IR Contacts
Media Fact sheets Glossary Image library Valerio Building Press Releases Scientific papers Technology Useful Links Media contacts	Careers Vacancies The Netherlands Switzerland Sweden UK US Spain Internships The Netherlands Benefits & Rewards Our Team Bert Bruni Martijn Olga Rubén

E-MAIL THIS PAGE

PRINT THIS PAGE

MoveNext - Latus